Dergiler / Erciyes Üniversitesi Veteriner Fakültesi Dergisi / 2019 / Cilt: 16 - Sayı: 1

The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen

Sayfa
23–29
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

According to the biological activity results, it can be concluded that these natural agents may be potentially used for veterinary sciences, food industry or pharmaceutical applications that aim to manage S. maltophilia biofilm.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aerobic, non-fermentative and Gram-negative Stenotrophomonas maltophilia is a multidrug-resistant bacilli that is known to be pathogen for human and animals.
📊
Temel Bulgular & Veri:Here in this study, its aimed to determine the inhibition activities of natural phenolic compounds eugenol and pulegone against S. maltophilia MU69.
💡
Sonuç & Katkı:According to the biological activity results, it can be concluded that these natural agents may be potentially used for veterinary sciences, food industry or pharmaceutical applications that aim to manage S. maltophilia biofilm.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Antibacterial · antibiofilm · eugenol

Özet

Aerobic, non-fermentative and Gram-negative Stenotrophomonas maltophilia is a multidrug-resistant bacilli that is known to be pathogen for human and animals. S. maltophilia has been isolated from different animal species and also found in a variety of environments including soil, water, and plants. S. maltophilia, which has the ability to form biofilms on surfaces that cause environmental problems, is resistant to many antibiotic classes such as cephalosporins, carbapenems, and aminoglycosides. Here in this study, its aimed to determine the inhibition activities of natural phenolic compounds eugenol and pulegone against S. maltophilia MU69. Antibacterial activities of eugenol and pulegone were initially determined by disc diffusion method. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) were also determined by tube dilution assay. Antibiofilm activities of the compounds were investigated by crystal violet staining and also monitorized using Scanning Electron Microscopy (SEM). Zone of inhibition measurements were found to be 39 mm and 28 mm for eugenol and pulegone, respectively. MIC and MBC values were found to be 3.12 mg/mL for eugenol while these were 2.5 mg/mL and 5 mg/mL for pulegone, respectively. The highest antibiofilm activity was found to be 56.30±0.45% for MIC of eugenol. To our knowledge, this is the first report of the antibacterial and antibiofilm activity of eugenol and pulegone against S. maltophilia. According to the biological activity results, it can be concluded that these natural agents may be potentially used for veterinary sciences, food industry or pharmaceutical applications that aim to manage S. maltophilia biofilm.

🔖

Bu Makaleye Atıf Yap

BAYGAR, T., SARAÇ, N., UĞUR, A., BALCI, U., BAYGAR, T. (2022). The Inhibition Effects of Eugenol and Pulegone on Stenotrophomonas maltophilia: an Opportunistic Pathogen. Erciyes Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 16 - Sayı: 1, 23–29. https://ajindex.com/articles/503769

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Albini S, Abril C, Franchini M, Hüssy D, Filioussis G. Stenotrophomonas maltophilia isolated from the airways of animals with chronic respiratory disease. Schweiz Arch Tierheilkd 2009
  2. 151(7): 323-8. 2.Ali SM, Khan AA, Ahmed I, Musaddiq M, Ahmed KS, Polasa H, Ahmed N. Antimicrobial activities of Eugenol and Cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Ann Clin Microbiol Antimicrob 2005
  3. 4(20): 1-7. 3.Alonso A, Martinez JL. Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1997
  4. 1140–2. 4.Al-Shabib NA, Husain FM, Ahmad I, Baig MH. Eugenol inhibits quorum sensing and biofilm of toxigenic MRSA strains isolated from food handlers employed in Saudi Arabia. Biotechnol Biotechnol Equip 2017
  5. 31(2): 387-96. 5.Avison MB, Higgins CS, von Heldreich CJ, Bennett PM, Walsh TR. Plasmid location and molecular heterogeneity of the L1 and L2-lactamase genes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2001
  6. 45(2):413-9. 6.Avison MB, von Heldreich CJ, Higgins CS, Bennett PM, Walsh TR. ATEM-2_-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J Antimicrob Chemother 2000
  7. 46(6): 879-84. 7.Bassolé IHN, Juliani HR. Essential oils in combination and their antimicrobial properties. Molecules 2012
  8. 17(4): 3989-4006. 8.Baygar T, Ugur A. In vitro Evaluation of Antimicrobial and Antibiofilm Potentials of Silver Nanoparticles Biosynthesized by Streptomyces griseorubens. IET Nanobiotechnol 2017
  9. 11(6): 667-81. 9.Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 2012
  10. 25(1): 2-41. 10.Chung HS, Hong SG, Kim YR, Shin KS, Whang DH, Ahn JY, Lee HS. Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates. J Korean Med Sci 2013
  11. 28 (1): 62-6. 11.CLSI-Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth Informational Supplement. Document M100-S16, Wayne, PA: Clinical and Laboratory Standards Institute, 2011. 12.Collins CH, Lyne PM, Grange JM, eds, Microbiological Methods, 7th ed, Butterworths, London, 1995
  12. p.493. 13.Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Adlem E. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resista